Πρόληψη αιφνιδίου καρδιακού θανάτου στους αθλητές

Similar documents
I have nothing to disclose. Research support from: Cardiac Risk in The Young

The frontier between normal and abnormal electrocardiogram in athletes

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Professor Sanjay Sharma St George s University of London

Interpretation and Consequences of Repolarisation Changes in Athletes

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

François Carré Hôpital Pontchaillou -INSERM UMR1099-Université Rennes 1

Η σημασία του ΗΚΓ ηρεμίας στη διαστρωμάτωση κινδύνου για αιφνίδιο θάνατο σε Νέους Αθλητές

at least 4 8 hours per week

Risk Factors for Sudden cardiac Death

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Pre-participation screening is warranted: Pro

SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

Cardiovascular Impacts of long-term endurance exercise: Implications of athlete s heart

INTERNATIONAL RUGBY BOARD Putting players first

Asymptomatic patient with WPW

Sudden Cardiac Arrest in Athletes: Can We Prevent Sudden Death?

Jonathan Kim MD, FACC

Jean François Leclercq Department of Rythmology Private Hospital of Parly 2 - Le Chesnay F

Prevention of Sudden Death in ARVC

EKG screening in athletics

Endurance sports and sudden cardiac death

SCREENING AND PREVENTING SUDDEN CARDIAC DEATH IN EXERCISE

Sudden cardiac death in athletes: in perspective and from different perspectives

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES

Silvia G Priori MD PhD

What genetic abnormalities should we search for after a sudden death?

Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In?

Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD

ECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director

Pre-Participation Cardiac Screening

Cardiac hypertrophy : differentiating disease from athlete

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

Asymptomatic Long QT. Prof. Dr. Martin Borggrefe Mannheim

Στυλιανός Τζέης MD, PhD, FESC

Cardiac Screening for Sports Participation: What s Good Enough?

Pearls of the ESC/ERS Guidelines 2015 Channelopathies

The sudden cardiac death (SCD)

WPW in Athletes Should we treat all? age? RAMI FOGELMAN SCHNEIDER CHILDREN MEDICAL CENTER OF ISRAEL

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

Sudden Death in Athletes: Is Screening Justified? Jacob Tfelt-Hansen MD DMSc. Associate Professor and Head of inherited Arrhythmia

Genotype Positive/ Phenotype Negative: Is It a Disease?

Abnormal ECG patterns and significance in a group of mountaineers

Dr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London

Benign RVOT Ectopy and RV dysplasia

Update on use of cardiac MRI in ARVC/D. Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology

Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada

6/19/2018. Background Athlete s heart. Ultimate question. Applying the International Criteria for ECG

Invasive Risk Stratification: When is it needed?

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring

Tachycardia Devices Indications and Basic Trouble Shooting

HYPERTROPHIC CARDIOMYOPATHY RISK STRATIFICATION WHAT IS NEW?

ARISTOTLE UNIVERSITY OF THESSALONIKI, GREECE SPORTS MEDICINE LABORATORY ΑΡΡΥΘΜΙA KAI SPORTS TO SCREEN OR NOT TO SCREEN

J-wave syndromes: update on ventricular fibrillation mechanisms

Sports Cardiology: Matters of the Heart. AMSSM Exchange Lecture AOSSM 2013 Annual Meeting

Zoll Medical--LifeVest:

2/26/2015.

Preventing Sudden Death in Young Athletes. Outline. Scope of the Problem. Causes of SCD in Young Athletes. Sudden death in the young athlete

Management of Syncope in Heart Failure. University of Iowa

Assessing and Managing the Health of a Young Athlete Predisposed to Myoneural Dysfunction

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

State of the Art: Brugada Syndrome Novel diagnostic approaches and risk stratification

Athletes with cardiac disease; dead and buried or chance for resurrection?

CONGENITAL CORONARY ARTERY ANOMALIES

Abbreviation List: 2017 by the American Heart Association, Inc. and the American College of Cardiology Foundation. 1

Rebuttal. Jerónimo Farré MD 2010

Name of Presenter: Marwan Refaat, MD

Sudden Cardiac Death in Korea : Epidemiology and Risk Factors

The First Large-scale Public Cardiac Screening to Protect Athletes Health in Hong Kong (CASPAR)

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex

Implantable loop recorders Michele Brignole Arrhythmologic Center, Lavagna, Italy

Tailored treatment in Brugada syndrome

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes

A new consensus document on electrocardiographic interpretation in athletes: does it help to prevent sudden cardiac death in athletes?

Current ECG interpretation guidelines in the screening of athletes

The Screening Debate. Robert M. Campbell, MD Children s Healthcare of Atlanta Emory University School of Medicine

Cardiac Screening before Participation in Sports

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives

SABIHA GATI AND SANJAY SHARMA

Ventricular tachyarrhythmias induced by exercise: are they an unsafe clinical pattern?

Sudden Death in Athletes: What is the role of ECG Screening?

9/23/2014. Genetics knowledge in cardiology is developing rapidly. Professional recommendations support cardiac genetic testing

Clinical aspects of Arrhythmogenic Cardiomyopathies

Το ΗΚΓ στις Μυοκαρδιοπάθειες και στην Περικαρδίτιδα

Continuous ECG telemonitoring with implantable devices: the expected clinical benefits

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

Assessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis

HF and CRT: CRT-P versus CRT-D

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Sudden death as co-morbidity in patients following vascular intervention

DELAYED ENHANCEMENT IMAGING IN CHILDREN

INNOVATIONS IN DEVICE THERAPY:

Defibrillation threshold testing should no longer be performed: contra

SUDDEN CARDIAC DEATH IN ATHLETES

Transcription:

Πρόληψη αιφνιδίου καρδιακού θανάτου στους αθλητές Σωκράτης Παστρωμάς Επιμελητής Α Τμήμα Ηλεκτροφυσιολογίας & Βηματοδότησης Ερρίκος Ντυνάν Hospital Center

Pheidippides sudden cardiac death in the Atheneum in 490 B.C Clin. Cardiol. 35, 2, 69 73 (2012)

European Heart Journal (2015) 36, 1445 1453

Detrimental effects of exercise European Heart Journal (2015) 36, 1445 1453

Cardiovascular and peripheral adaptation to exercise in athletes 5-6 fold increase in cardiac output European Heart Journal (2015) 36, 1445 1453

Athletes heart vs. cardiomyopathy European Heart Journal (2015) 36, 1445 1453

Definition Epidemiology Incidence in athletes 35 yrs old is 0.6 to 3.6 per 100,000 population per year 10-fold greater risk in males compared to females The risk of SCD is greater in athletes >35 yrs old Adolescent and young adults involved in sports activity have an estimated risk of SCD that is 2.8 times greater than that of their nonathletic counterparts JACC Cardiovasc Imaging. 2013;6:993-1007 Card Electrophysiol Clin 5 (2013) 13 21

Circulation 2012;125:2511-2516.

Circulation 2009;119:1085-1092

Distribution of cardiovascular causes of sudden death in 1435 young competitive athletes. From the Minneapolis Heart Institute Foundation Registry, 1980 to 2005 Circulation. 2007;115:1643-1655

Post mortem cardiac pathology findings 1994-2014 40% of cases: myocardial disease

ESC, IOC, FIFA, NBA endorse cardiovascular screening including ECG AHA recommends screening using a health questionnaire and a brief physical examination without ECG

Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program in Veneto prescreening period early screening period late screening period RR of SCD 44% lower RR of SCD 79% lower The annual incidence of SCD in athletes decreased by 89%, from 3.6 per 100,000 person-years during the prescreening period to 0.4 per 100,000 person-years during the late screening period Mortality reduction was predominantly due to a lower incidence of sudden death from cardiomyopathies JAMA 2006;296:1596

>80% <5%

University athletes (n=508) underwent routine medical history/physical examination and ECG before athletic participation Application of the 2010 ESC criteria, compared with the 2005 criteria, reduced the number of participants with abnormal ECG findings from 83/508 (16.3%) to 49/508 (9.6%) Heart 2011;97:1573e1577

2015 ESC Guidelines for SCD (in athletes) European Heart Journal (2015) 36, 2793 2867

785 athletes (73% males, 46.8±7.3 years) were enrolled over a 13-month period. 14.3% required additional examinations: 5.1% because of abnormal ECG, 4.7% due to physical examination, 4.1% because of high cardiovascular risk and 1.6% due to medical history. A new cardiovascular abnormality was established in 2.8% of athletes Conclusions: Cardiovascular evaluation of middle-aged athletes detected a new cardiovascular abnormality in about 3% of participants and a high-cardiovascular risk profile in about 4% Br J Sports Med 2014;0:1 6.

Performed by physicians or nurse practitioners/physician-assistants formally trained in physical examination techniques to perform athletic screening evaluations Not routine use of ECG Circulation. 2007;115:1643-1655

15 papers, 47,137 athletes Journal of Electrocardiology 48 (2015) 329 338

21 athletes with resuscitated cardiac arrest or SCD vs. 365 healthy athletes ECG analyses: J-point elevation (J wave), slurred QRS complex, & ST-segment elevation QRS slurring or J wave in the absence of ST elevation in the inferior-lateral ECG leads was associated with increased risk of CA or SD, whereas the presence of ST-segment elevation did not appear to increase such risk Circ Arrhythm Electrophysiol. 2010;3:305-311

Recommendations for competitive sports participation in athletes with potential causes of SCD J Am Coll Cardiol 2013;61:1027 40

372 athletes, age 10-60 yrs, median time since implantation was 27 mo, median f-u 31 mo Most of them: HCM, ARVC, LQTS 13% at least 1 appropriate shock 11% at least 1 inappropriate shock Freedom from lead malfunction was 97% at 5 years (from implantation) and 90% at 10 years Circulation. 2013;127:2021-2030